Company · CIK 0001582313 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Xenon Pharmaceuticals Inc. · XENE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 8:26 pm EDT | Dawn SvoronosDirector | 5,144 | $8.15 | $41,924 | 31,373 | — | |
| Aug 28, 2026 SForm 4 → | Aug 31, 9:59 pm EDT | Christopher John KenneyChief Medical Officer | 7,068 | $60.25 | $425,829 | 2 | −100.0% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 4:33 pm EDT | Steven GannonDirector | 10,000 | $64.06 | $640,550 | 1,870 | −84.2% | |
| Jun 5, 2026 SForm 4 → | Jun 8, 9:19 pm EDT | Gary PatouDirector | 1,322 | $53.14 | $70,251 | 24,896 | −5.04% | 10b5-1 |
| Jun 5, 2026 SForm 4 → | Jun 8, 9:19 pm EDT | Gillian CannonDirector | 1,190 | $53.14 | $63,237 | 1,455 | −45.0% | 10b5-1 |
| Jun 1, 2026 MForm 4 → | Jun 3, 9:04 pm EDT | Gary PatouDirector | 2,645 | — | — | 26,218 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 9:04 pm EDT | Patrick MachadoDirector | 2,645 | — | — | 2,645 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 9:04 pm EDT | Justin D. GoverDirector | 2,645 | — | — | 2,645 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 9:04 pm EDT | Elizabeth A. GarofaloDirector | 2,645 | — | — | 2,645 | — | |
| Jun 1, 2026 FMForm 4 → | Jun 3, 9:04 pm EDT | Steven GannonDirector | 4,061 | $53.41 | $75,629 | 11,870 | — | |
| Jun 1, 2026 MForm 4 → | Jun 3, 9:03 pm EDT | Gillian CannonDirector | 2,645 | — | — | 2,645 | — | |
| Jun 1, 2026 FMForm 4 → | Jun 3, 9:03 pm EDT | Dawn SvoronosDirector | 4,061 | $53.41 | $75,629 | 26,229 | — | |
| Mar 11, 2019 GForm 4 → | Mar 12, 5:00 pm EDT | Michael R HaydenDirector | 41,382 | — | — | 114,403 | — | plan? |
| Dec 21, 2018 GForm 4 → | Dec 26, 11:00 am EST | Michael M TarnowDirector | 5,000 | — | — | 62,512 | — | plan? |
| Dec 14, 2018 MForm 4 → | Dec 18, 4:06 pm EST | Gary PatouDirector | 2,057 | $3.07 | $6,315 | 19,459 | — | plan? |
| Dec 11, 2018 FMForm 4 → | Dec 13, 1:56 pm EST | Charles J. CohenVP, Biology | 5,759 | $4.19 | $24,141 | 6,550 | — | plan? |
| Dec 6, 2018 MForm 4 → | Dec 10, 9:10 pm EST | Mohammad AzabDirector | 3,086 | $3.07 | $9,474 | 57,584 | — | plan? |
| Jun 21, 2018 MForm 4 → | Jun 22, 4:40 pm EDT | Michael M TarnowDirector | 12,345 | $3.43 | $42,354 | 67,512 | — | plan? |
| Jun 21, 2018 MForm 4 → | Jun 22, 4:39 pm EDT | Mohammad AzabDirector | 10,288 | $3.70 | $38,066 | 54,498 | — | plan? |
| Jun 14, 2018 FMForm 4 → | Jun 15, 7:32 pm EDT | Gary PatouDirector | 11,086 | $4.89 | $54,156 | 17,402 | — | plan? |
| Mar 27, 2018 JForm 4 → | Mar 29, 6:37 pm EDT | BVF PARTNERS L P/IL +610% Owner | 2,437,000 | — | — | 59,464 | — | plan? |
| Mar 15, 2018 FMForm 4 → | Mar 16, 4:33 pm EDT | Sherrington RobinEVP Bus. & Corp. Development | 5,014 | $4.10 | $20,551 | 5,892 | — | plan? |
| Mar 14, 2018 MForm 4 → | Mar 16, 4:23 pm EDT | Frank A HollerDirector | 3,086 | $3.77 | $11,634 | 118,955 | — | plan? |
| Mar 12, 2018 MForm 4 → | Mar 14, 4:52 pm EDT | Simon N. PimstoneCEO, Director | 10,288 | $3.77 | $38,786 | 228,135 | — | plan? |
| Feb 22, 2018 GForm 4 → | Mar 1, 6:25 pm EST | Michael R HaydenDirector | 50,760 | — | — | 97,066 | — | plan? late |
| Feb 12, 2018 FMForm 4 → | Feb 14, 5:55 pm EST | Charles J. CohenVP, Biology | 49,417 | $3.61 | $178,577 | 4,079 | — | plan? |
| Nov 15, 2017 PForm 4 → | Nov 16, 4:56 pm EST | Mohammad AzabDirector | 15,000 | $2.22 | $33,281 | 44,210 | +51.4% | plan? |
| Sep 21, 2017 PForm 4 → | Sep 25, 5:00 pm EDT | Mohammad AzabDirector | 10,000 | $2.95 | $29,500 | 29,210 | +52.1% | plan? |
| Aug 18, 2017 PForm 4 → | Aug 21, 4:48 pm EDT | Raymond WinquistHead, Translational Research | 1,000 | $3.00 | $2,995 | 1,000 | — | plan? |
| Aug 17, 2017 PForm 4 → | Aug 21, 4:49 pm EDT | Mohammad AzabDirector | 6,335 | $2.90 | $18,363 | 19,210 | +49.2% | plan? |
| Aug 15, 2017 PForm 4 → | Aug 17, 5:33 pm EDT | James R. EmpfieldSVP, Drug Discovery | 10,000 | $2.48 | $24,824 | 10,000 | — | plan? |
| Aug 14, 2017 PForm 4 → | Aug 16, 6:55 pm EDT | BVF PARTNERS L P/IL +610% Owner | 60,202 | $2.61 | $157,267 | 1,077,694 | +5.92% | plan? |
| Aug 14, 2017 PForm 4 → | Aug 15, 4:54 pm EDT | Dawn SvoronosDirector | 50,000 | $2.82 | $140,770 | 50,000 | — | plan? |
| Aug 14, 2017 PForm 4 → | Aug 14, 6:06 pm EDT | Michael R HaydenDirector | 15,000 | $2.75 | $41,247 | 161,187 | +10.3% | plan? |
| Aug 11, 2017 PForm 4 → | Aug 14, 6:05 pm EDT | Steven GannonDirector | 15,000 | $2.82 | $42,267 | 15,000 | — | plan? |
| Aug 10, 2017 PForm 4 → | Aug 14, 6:07 pm EDT | Gary PatouDirector | 7,500 | $2.78 | $20,836 | 12,500 | +150% | plan? |
| Aug 10, 2017 PForm 4 → | Aug 14, 6:07 pm EDT | Ian MortimerCFO & COO | 15,000 | $2.88 | $43,225 | 14,300 | — | plan? |
| Aug 10, 2017 PForm 4 → | Aug 14, 6:07 pm EDT | Richard H SchellerDirector | 7,000 | $2.85 | $19,950 | 7,000 | — | plan? |
| Aug 10, 2017 PForm 4 → | Aug 14, 6:06 pm EDT | Simon N. PimstonePresident & CEO, Director | 6,000 | $2.90 | $17,400 | 217,847 | +2.83% | plan? |
| Aug 8, 2017 PForm 4 → | Aug 10, 7:58 pm EDT | Gary PatouDirector | 5,000 | $3.00 | $15,003 | 5,000 | — | plan? |
| Jun 27, 2017 PForm 4/A → | Jun 30, 12:00 pm EDT | BVF PARTNERS L P/IL +610% Owner | 85,461 | $3.04 | $259,468 | 297,464 | +40.3% | plan? |
| Jun 27, 2017 PForm 4 → | Jun 29, 6:21 pm EDT | BVF PARTNERS L P/IL +610% Owner | 85,461 | $4.00 | $341,844 | 297,464 | +40.3% | plan? |
| Jun 21, 2017 PForm 4 → | Jun 23, 7:16 pm EDT | BVF PARTNERS L P/IL +610% Owner | 20,411 | $4.00 | $81,644 | 288,968 | +7.60% | plan? |
| Jun 19, 2017 GMForm 4 → | Jun 20, 4:37 pm EDT | Michael M TarnowDirector | 2,056 | $3.51 | $3,608 | 55,167 | — | plan? |
| Jun 15, 2017 PForm 4 → | Jun 19, 7:33 pm EDT | BVF PARTNERS L P/IL +610% Owner | 26,408 | $3.84 | $101,518 | 286,752 | +10.1% | plan? |
| Jun 6, 2017 PForm 4 → | Jun 8, 6:58 pm EDT | BVF PARTNERS L P/IL +610% Owner | 358,698 | $3.81 | $1,366,146 | 284,171 | — | plan? |
| May 12, 2017 FMForm 4 → | May 16, 4:32 pm EDT | Sherrington RobinSVP Bus. & Corp. Development | 3,402 | $3.59 | $12,225 | 4,734 | — | plan? |
| Mar 14, 2017 MForm 4 → | Mar 15, 7:53 pm EDT | Michael R HaydenDirector | 60,698 | $3.67 | $222,911 | 30,348 | — | plan? |
| Jan 26, 2017 GForm 4 → | Jan 27, 5:27 pm EST | Michael M TarnowDirector | 7,201 | — | — | 55,167 | — | plan? |
| Dec 15, 2016 SForm 4 → | Dec 19, 5:07 pm EST | Frank A HollerDirector | 30,000 | $7.85 | $235,500 | 115,869 | −20.6% | plan? |
| Dec 12, 2016 GMForm 4 → | Dec 13, 4:57 pm EST | Michael M TarnowDirector | 21,605 | $3.21 | $46,234 | 62,368 | — | plan? |
| Dec 6, 2016 FMForm 4 → | Dec 8, 4:52 pm EST | Gary PatouDirector | 16,748 | $4.44 | $74,411 | 12,028 | — | plan? |
| Dec 1, 2016 FMForm 4 → | Dec 2, 6:05 pm EST | Mohammad AzabDirector | 16,753 | $4.42 | $74,010 | 12,875 | — | plan? |
| Aug 19, 2016 SForm 4 → | Aug 23, 4:51 pm EDT | Frank A HollerDirector | 11,938 | $7.65 | $91,338 | 145,869 | −7.56% | plan? |
| Aug 16, 2016 SForm 4 → | Aug 18, 8:24 pm EDT | Frank A HollerDirector | 18,062 | $7.93 | $143,156 | 157,807 | −10.3% | plan? |
| Jul 29, 2016 FMForm 4 → | Aug 2, 5:10 pm EDT | Simon N. PimstonePresident & CEO, Director | 17,048 | $4.45 | $75,823 | 211,847 | — | plan? |
| Jun 24, 2016 PForm 4 → | Jun 28, 4:41 pm EDT | Ian MortimerCFO & COO | 5,300 | $6.22 | $32,940 | 4,300 | — | plan? |
| May 25, 2016 MForm 4 → | May 27, 5:07 pm EDT | Michael R HaydenDirector | 8,230 | $3.30 | $27,159 | 18,518 | — | plan? |
| Apr 28, 2016 GMForm 4 → | Apr 29, 6:12 pm EDT | Michael M TarnowDirector | 3,086 | $3.35 | $5,169 | 55,167 | — | plan? |
| Dec 16, 2015 FMForm 4 → | Dec 21, 6:06 am EST | Sherrington RobinSVP Bus. & Corp. Development | 640 | $6.19 | $3,964 | 4,022 | — | plan? late |
| Dec 11, 2015 MForm 4 → | Dec 14, 5:37 pm EST | Mohammad AzabDirector | 2,469 | $5.22 | $12,888 | 4,938 | — | plan? |
| Nov 24, 2015 FMForm 4 → | Nov 25, 3:50 pm EST | Frank A HollerDirector | 3,052 | $6.58 | $20,081 | 175,869 | — | plan? |
| Nov 4, 2015 FMForm 4 → | Nov 6, 5:20 pm EST | Gary PatouDirector | 5,452 | $6.33 | $34,520 | 4,086 | — | plan? |
| Nov 2, 2015 GMForm 4 → | Nov 4, 6:43 pm EST | Michael M TarnowDirector | 10,082 | $5.22 | $26,314 | 55,167 | — | plan? |
| Sep 22, 2015 SForm 4 → | Sep 24, 9:56 pm EDT | Y. Paul GoldbergVP of Clinical Development | 22,149 | $8.88 | $196,664 | 6,000 | −78.7% | plan? |
| Sep 22, 2015 FMForm 4 → | Sep 24, 9:56 pm EDT | Y. Paul GoldbergVP of Clinical Development | 38,730 | $4.60 | $178,013 | 28,149 | — | plan? |
| Aug 18, 2015 FMForm 4 → | Aug 20, 1:13 pm EDT | Sherrington RobinSVP Bus. & Corp. Development | 4,387 | $6.73 | $29,511 | 3,840 | — | plan? |
| Aug 18, 2015 FMForm 4 → | Aug 20, 1:11 pm EDT | Simon N. PimstonePresident & CEO, Director | 29,254 | $6.74 | $197,052 | 204,205 | — | plan? |
| Aug 18, 2015 FMForm 4 → | Aug 20, 1:08 pm EDT | Frank A HollerDirector | 2,925 | $6.77 | $19,792 | 174,807 | — | plan? |
| Aug 18, 2015 FMForm 4 → | Aug 20, 1:04 pm EDT | Y. Paul GoldbergVP of Clinical Development | 4,387 | $6.73 | $29,511 | 6,103 | — | plan? |
| Jun 17, 2015 MForm 4 → | Jun 19, 4:31 pm EDT | Michael M TarnowDirector | 1,543 | $4.95 | $7,638 | 55,167 | — | plan? |
| Apr 30, 2015 JForm 4 → | May 4, 7:28 pm EDT | Evan A. SteinDirector | 1,952,755 | — | — | 4,172 | — | plan? |
| Feb 3, 2015 MForm 4 → | Feb 5, 6:09 pm EST | Michael R HaydenDirector | 5,144 | $4.81 | $24,743 | 10,288 | — | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:08 pm EST | Michael M TarnowDirector | 5,041 | $4.98 | $25,104 | 53,624 | — | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:06 pm EST | Michael R HaydenDirector | 5,144 | $4.98 | $25,617 | 5,144 | — | plan? |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:04 pm EST | Mohammad AzabDirector | 2,469 | $4.98 | $12,296 | 2,469 | — | plan? |
| Jan 7, 2015 FMForm 4/A → | Jan 21, 8:13 pm EST | Gary PatouDirector | 4,450 | $8.68 | $38,648 | 2,544 | — | plan? |
| Jan 7, 2015 MForm 4 → | Jan 9, 8:30 pm EST | Gary PatouDirector | 3,497 | $4.98 | $17,415 | 3,497 | — | plan? amended |
| Dec 31, 2014 JForm 4 → | Jan 7, 2015, 12:57 pm EST | MX Associates, LLP10% Owner | 1,474,660 | — | — | 0 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2015 AForm 4 → | May 6, 3:44 pm EDT | Mohammad AzabDirector | 3,086 | — | — | 3,086 | — | |
| May 4, 2015 AForm 4 → | May 6, 3:43 pm EDT | Richard H SchellerDirector | 3,086 | — | — | 3,086 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:59 pm EDT | Sherrington RobinSVP Bus. & Corp. Development | 35,000 | — | — | 35,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:57 pm EDT | Simon N. PimstonePresident & CEO, Director | 95,000 | — | — | 95,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:55 pm EDT | Ian MortimerCFO & COO | 55,000 | — | — | 55,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:53 pm EDT | Y. Paul GoldbergVP, Clinical Development | 35,000 | — | — | 35,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:52 pm EDT | Karen G. CorrainiGen. Counsel & Corp. Secretary | 35,000 | — | — | 35,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 8:50 pm EDT | Charles J. CohenVP, Biology | 35,000 | — | — | 35,000 | — | |
| Mar 16, 2015 AForm 4 → | Mar 18, 6:47 pm EDT | Richard H SchellerDirector | 5,144 | — | — | 5,144 | — | |
| Feb 3, 2015 MForm 4 → | Feb 5, 6:09 pm EST | Michael R HaydenDirector | 5,144 | — | — | 0 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:08 pm EST | Michael M TarnowDirector | 5,041 | — | — | 0 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:06 pm EST | Michael R HaydenDirector | 5,144 | — | — | 0 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 7:04 pm EST | Mohammad AzabDirector | 2,469 | — | — | 0 | — | |
| Jan 7, 2015 MForm 4/A → | Jan 21, 8:13 pm EST | Gary PatouDirector | 3,497 | — | — | 0 | — | |
| Jan 7, 2015 MForm 4 → | Jan 9, 8:30 pm EST | Gary PatouDirector | 3,497 | — | — | 0 | — | amended |